Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Oct 26, 2021

BUY
$68.18 - $87.25 $136 - $174
2 Added 3.57%
58 $4,000
Q1 2021

Apr 30, 2021

SELL
$65.32 - $76.01 $79,167 - $92,124
-1,212 Reduced 95.58%
56 $3,000
Q3 2020

Oct 06, 2020

BUY
$55.23 - $62.39 $662 - $748
12 Added 0.96%
1,268 $72,000
Q2 2020

Jul 10, 2020

BUY
$49.45 - $64.16 $59,340 - $76,992
1,200 Added 2142.86%
1,256 $71,000
Q4 2019

Jan 22, 2020

SELL
$55.04 - $59.27 $2,201 - $2,370
-40 Reduced 41.67%
56 $3,000
Q3 2019

Oct 15, 2019

BUY
$58.2 - $62.42 $5,587 - $5,992
96 New
96 $5,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $43.5B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.